Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Orexigen puts US obesity drug development on hold, cites FDA demands, shares skid in premarket
Orexigen puts US obesity drug development on hold, cites FDA demands, shares skid in premarket
Orexigen puts US obesity drug development on hold, cites FDA demands, shares skid in premarket
Submitted by
admin
on June 3, 2011 - 9:19am
Source:
Yahoo/AP
News Tags:
FDA
Orexigen
obesity
Contrave
Headline:
Orexigen puts US obesity drug development on hold, cites FDA demands, shares skid in premarket
Do Not Allow Advertisers to Use My Personal information
